Clinical Trial Update: GMCI, Nivolumab, and Radiation Therapy in Treating Patients With Newly Diagnosed High-Grade Gliomas [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating GMCI in combination with nivolumab and radiation therapy for newly diagnosed high-grade gliomas has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• GMCI
• nivolumab (nivolumab)

Snippet

Sponsor: Candel Therapeutics, Inc. | Conditions: Glioma, Malignant | Phase 1 | Status: COMPLETED